查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1456997

全球移植市场 - 2024 年至 2029 年预测

Global Transplant Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

移植市场预计将以9.35%的复合年增长率成长，市场规模从2022年的167.09亿美元增至2029年的312.38亿美元。

移植是指将组织标本或完整器官从原来的位置移植或转移到另一个位置的过程。与原来的位置相比，移植的器官和组织在一个新的、更健康的环境中得到滋养和生长。移植过程是目前医疗领域广泛采用的过程。移植过程广泛用于肾臟、心臟和肝臟等组织和器官。医疗领域发展出来的移植技术为医疗领域带来了新的发展和创新。慢性病患者数量的增加和手术数量的增加正在推动全球移植市场的成长。人们的健康意识和认识的提高也推动了全球移植市场的成长。政府对促进器官库和器官移植的支持也促进了全球移植市场的成长。国际医疗组织的宣传计画也在促进和鼓励器官和组织捐赠，为全球移植市场的成长做出贡献。此外，由于器官登记率的提高，预计未来几年对器官移植的需求将会增加。器官移植领域进行的研发过程正在为器官移植市场带来先进的发展与创新。艾伯维公司（Abbvie Inc.）和Arthrex Inc.等大公司对器官移植的投资正在推动全球移植市场的成长。

市场驱动因素：

  • 器官移植需求增加，慢性疾病患者增加

器官移植的需求和普及不断增长正在推动全球器官和组织移植市场的成长。移植方法和手术提供的效率以及移植方法的成功率为全球移植市场的成长提供了潜力。根据PAHO（泛美卫生组织）的报告，美国每年大约进行100例或更多的肺移植手术。美国卫生与公众服务部表示，截至 2021 年，全国移植等待名单上约有 107,000 人。器官移植和器官登记率的不断上升正在推动全球移植市场的市场规模不断扩大。慢性病盛行率上升也是推动全球移植市场成长的关键因素之一。根据美国肺臟协会（ALA）的资料，2018年约有900万成年人患有慢性支气管炎，导致肺移植或手术。 ALA 也估计，美国每年报告约 20 万例新肺癌病例。作为某些慢性疾病的有效治疗方法，器官和组织移植的需求不断增长，正在推动全球移植市场的成长。

  • 政府措施和支持

政府和其他组织提供的高水准支持是推动全球移植市场成长的关键因素之一。政府措施和政策正在推动全球移植市场的成长。透过政府和私人公司合作开发的器官和组织库也正在推动全球移植市场的成长。企业对器官移植市场的大量投资正在推动全球移植领域的市场开拓和创新。此外，领先公司推出的新 3D 技术和先进功能的开发正在推动全球移植市场的成长。公共宣传活动、教育计划和立法行动等政府措施可以提高器官捐赠的意识并增加捐赠器官的可用性。它还建立和执行器官移植的法律规范，分配研究和开发资金，并加强包括移植中心在内的卫生基础设施，以确保安全有效的移植程序。

北美地区预计将主导市场

按地区划分，北美地区预计将在全球移植市场中显着成长。发达的基础设施和大公司的存在正在促进北美地区的市场成长。慢性病的存在和发生率的增加也推动了全球移植市场的成长。由于其先进的医疗基础设施、研究和创新、慢性病的高发病率、成熟的器官采购和移植网络、法规环境以及供体器官的可用性，北美预计将主导全球移植市场。 。该地区先进的医疗设施为器官移植手术的成功提供了支持。末期肾功能衰竭、肝功能衰竭和心臟衰竭等慢性疾病的高盛行率正在推动移植手术的需求。法规环境，包括器官共享联合网路等组织的监督，正在影响移植市场。意识提升的努力有助于增加捐赠器官的可用性。

主要进展

  • 2022 年 10 月 - 蔡司医疗技术公司的新一代电外科双极钳 MTLawton 获得 FDA 批准。这些镊子由特殊的铜基合金製成，可减少组织粘连和凝固，从而实现高效的准备。延长轴也减少了手术视野中的视觉限制，使外科医生在电外科手术期间更有效地进行操作。
  • 2022 年 3 月 - Biocomposites 与全球医疗技术领导者 Zimmer Biomet 合作，在美国整形外科市场销售 Genex 骨移植替代品。这种双相复合材料旨在平衡骨传导支架的强度及其在体内的持久性，从而实现最佳的骨架构重建。这份新合约包括针对美国市场的新型封闭式混合系统，减少了准备时间并增加了生产时间。 Genex 还提供更全面的输送选项，让外科医生可以根据他们喜欢的程序注射、成型和准备珠子。

目录

第一章 简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章 全球移植市场：依类型

  • 介绍
  • 组织移植
  • 器官移植

第六章 全球移植市场：依最终用途分类

  • 介绍
  • 医院
  • 移植中心
  • 其他的

第七章全球移植市场：按地区

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章 公司简介

  • Abbvie Inc.
  • Arthrex Inc.
  • Medtronic PLC
  • Teva Pharmaceuticals
  • Zimmer Biomet
  • Strykers
  • Novartis AG
  • Veloxis Pharmaceuticals
  • 21st Century Medicin
  • BiolifeSolutions Inc
简介目录
Product Code: KSI061612245

The transplant market is expected to grow at a CAGR of 9.35%, reaching a market size of US$31.238 billion in 2029 from US$16.709 billion in 2022.

Transplantation is the process of a tissue specimen or a complete organ being transplanted or transferred to another place from its original site. The transplanted organ or tissue will have nourishment and develop in the new, healthier environment compared to the original site. The transplant process is a process that is widely employed in the current medical and healthcare field. The transplantation process is widely used in the case of tissues and organs such as kidneys, hearts, livers, and so on. The transplantation techniques developed in the medical field have given way to new developments and innovations in the medical field. The increasing number of cases of chronic diseases and the rising number of surgeries are driving the market growth of the global transplant market. The rising health awareness and consciousness of people are also driving the market growth of the global transplant market. The support of the government in promoting organ banks and organ transplantation is also contributing to the market growth of the global transplant market. International healthcare organizations' awareness programs are also promoting and encouraging people to donate organs and tissues, which contributes to the global transplant market's growth. The rising rate of organ registration is also expected to increase the demand for organ transplants in the upcoming years. The research and development process taking place in the organ transplant field is resulting in advanced developments and innovations in the organ transplant market. The investment of major players like Abbvie Inc. and Arthrex Inc. in organ transplantation is fuelling the growth of the global transplant market.

MARKET DRIVERS:

  • Rising Demand for Organ Transplants and Increasing Cases of Chronic Diseases

The increasing demand and popularity of organ transplantation are boosting the market growth of the global organ and tissue transplant market. The efficiency offered by transplantation methods or surgeries and the success rate of transplant methods are giving potential to the growth of the global transplant market. According to the reports of PAHO (Pan American Health Organisation), about 100+ lung transplantation surgeries take place in the United States every year. The United States Department of Health and Human Services states that about 107,000 people are on the national transplant waiting list as of 2021. The increased rate of organ transplantation and organ registration is raising the market size of the global transplant market. The rising incidence of chronic diseases is also one of the major factors driving the growth of the global transplant market. According to the data from the ALA (American Lung Association), about 9 million adults suffered from chronic bronchitis in 2018, which led to lung transplantation and surgery. ALA also states that around 200,000 new lung cancers are reported in the U.S. every year. The rising demand for organ and tissue transplantation as an effective treatment for some chronic diseases is driving the market growth of the global transplant market.

  • Government Initiatives and Support

The high level of support offered by governments and other organizations is one of the major factors driving the market growth of the global transplant market. Government initiatives and policies are assisting in the growth of the global transplant market. The organ and tissue banks developed by the collaboration of governments and private companies are also fuelling the growth of the global transplant market. The high investment of companies in the organ transplant market is enhancing the development and innovations in the global transplant field. The development of new 3D technologies and advanced features in the field introduced by major companies is also fuelling the growth of the global transplant market. Government initiatives, including public campaigns, education programs, and legislative measures, can increase organ donation awareness and increase donor organ availability. They also establish and enforce regulatory frameworks for organ transplantation, allocate funding for research and development, and enhance healthcare infrastructure, including transplant centers, to ensure safe and effective transplant procedures.

The region of North America is anticipated to dominate the market

Geographically, the North American region is expected to showcase drastic growth in the global transplant market. The well-developed infrastructure and the presence of leading companies are contributing to the market growth in the North American region. The presence and increasing rate of chronic diseases are also propelling the growth of the global transplant market. North America is expected to dominate the global transplant market due to its advanced healthcare infrastructure, research and innovation, high incidence of chronic diseases, well-established organ procurement and transplantation networks, regulatory environment, availability of donor organs, economic factors, and collaborations between transplant centers, healthcare institutions, and pharmaceutical companies. The region's advanced medical facilities support successful implementation of organ transplantation procedures. The high incidence of chronic diseases, such as end-stage renal disease, liver failure, and heart failure, drives the demand for transplant procedures. The regulatory environment, including oversight by organizations like the United Network for Organ Sharing, influences the transplantation market. The region's efforts in promoting organ donation and transplantation awareness contribute to the higher availability of donor organs.

Key Developments:

  • October 2022- ZEISS Medical Technology has received FDA clearance for its new MTLawton, a new generation of bipolar forceps for electrosurgery. These forceps, made from a special copper-base alloy, reduce tissue adhesion and coagulation for efficient preparation. The extended shaft also reduces visual restrictions in the surgical field, allowing surgeons to perform more efficiently during electrosurgical procedures. The forceps are expected to reduce tissue adhesion and charring during tissue dissection.
  • March 2022- Biocomposites has partnered with global medical technology leader Zimmer Biomet to distribute Genex Bone Graft Substitute in the U.S. orthopedic market. The biphasic composite is designed to balance osteoconductive scaffold strength and persistence in the body, enabling optimal bone architecture remodeling. The new agreement includes a new closed-mixing system for the U.S. market, reducing preparation time and extending working time. Genex also offers a more comprehensive set of delivery options, allowing surgeons to inject, mold, or prepare beads according to their preferred technique.

Market Segmentation

By Type

  • Tissue Transplant
  • Organ Transplant

By End-Use

  • Hospitals
  • Transplant Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL TRANSPLANT MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Tissue Transplant
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Organ Transplant
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. GLOBAL TRANSPLANT MARKET, BY END-USE

  • 6.1. Introduction
  • 6.2. Hospitals
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Transplant Centers
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Others
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. GLOBAL TRANSPLANT MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Type
    • 7.2.2. By End-Use
    • 7.2.3. By Country
      • 7.2.3.1. USA
        • 7.2.3.1.1. Market Opportunities and Trends
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Opportunities and Trends
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Opportunities and Trends
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Type
    • 7.3.2. By End-Use
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Opportunities and Trends
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Opportunities and Trends
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Opportunities and Trends
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Type
    • 7.4.2. By End-Use
    • 7.4.3. By Country
      • 7.4.3.1. Germany
        • 7.4.3.1.1. Market Opportunities and Trends
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. France
        • 7.4.3.2.1. Market Opportunities and Trends
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. UK
        • 7.4.3.3.1. Market Opportunities and Trends
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Others
        • 7.4.3.4.1. Market Opportunities and Trends
        • 7.4.3.4.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Type
    • 7.5.2. By End-Use
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Opportunities and Trends
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Opportunities and Trends
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Others
        • 7.5.3.3.1. Market Opportunities and Trends
        • 7.5.3.3.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Type
    • 7.6.2. By End-Use
    • 7.6.3. By Country
      • 7.6.3.1. China
        • 7.6.3.1.1. Market Opportunities and Trends
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. India
        • 7.6.3.2.1. Market Opportunities and Trends
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. Japan
        • 7.6.3.3.1. Market Opportunities and Trends
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. South Korea
        • 7.6.3.4.1. Market Opportunities and Trends
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Taiwan
        • 7.6.3.5.1. Market Opportunities and Trends
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Thailand
        • 7.6.3.6.1. Market Opportunities and Trends
        • 7.6.3.6.2. Growth Prospects
      • 7.6.3.7. Indonesia
        • 7.6.3.7.1. Market Opportunities and Trends
        • 7.6.3.7.2. Growth Prospects
      • 7.6.3.8. Others
        • 7.6.3.8.1. Market Opportunities and Trends
        • 7.6.3.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Abbvie Inc.
  • 9.2. Arthrex Inc.
  • 9.3. Medtronic PLC
  • 9.4. Teva Pharmaceuticals
  • 9.5. Zimmer Biomet
  • 9.6. Strykers
  • 9.7. Novartis AG
  • 9.8. Veloxis Pharmaceuticals
  • 9.9. 21st Century Medicin
  • 9.10. BiolifeSolutions Inc